Why YS Biopharma Stock Is Rocketing Higher

YS Biopharma Co., Ltd. YS shares are rocketing higher Friday after the company announced the purchase of shares by company officers.

The Details:

YS Biopharma announced that chairperson, Mr. Yi Zhang, and its CEO, Dr. Hui Shao, have purchased 429,188 of the company's ordinary shares at an average price of $1.407 per share, and 46,300 ordinary shares at an average price of $1.46 per share on the open market.

YS shares are moving higher on very heavy trading volume. According to data from Benzinga Pro, more than 35.2 million shares have been traded in the session, far exceeding the stock's 100-day average of just over 651 thousand shares.

YS Biopharma is currently one of the top trending tickers on Yahoo! Finance

Related News: What's Going On With Ideanomics Stock Today?

YS Price Action: According to Benzinga Pro, YS Biopharma shares are up 50% at $1.17 at the time of publication.

Image: TheDigitalArtist from Pixabay

Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Posted In:
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!